News

Neurodegenerative diseases like Parkinson’s and Alzheimer’s affect millions of people and are becoming more common as the ...
The human brain comprises billions of neurons, synapses, and cell types, making it one of the universe's most intricate and ...
Psychedelics like ketamine and LSD straddle a fine line—offering therapeutic promise under medical supervision, yet posing ...
The endorsement means the EMA will offer Carthera support and advice as it moves towards a regulatory filing for its SonoCloud ultrasound system.
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
Discover 5 dangerous drug-resistant fungi posing epidemic threats. Learn how these deadly superbugs are spreading and what ...
A common blood test can flag early Alzheimer's disease patients who are four times more likely to experience rapid brain decline, a new study says.
New technologies to shuttle drugs into the brain are showing promise in Alzheimer’s disease, cancer and more.
Discover how blood-brain barrier protection through a new drug could prevent neurodegeneration and cognitive decline in Alzheimer’s patients.
The properties of the blood-brain barrier serve a vital protective role, but they also keep drugs from reaching the organ. Big pharmaceutical companies have been making deals for technologies that ...